RT @LudwigLin: @drlaurajwaters there's a cardiovascular study (EMPHASIS-HF) with eplerenone that looks promising, as is a meta-analysis in…
@drlaurajwaters there's a cardiovascular study (EMPHASIS-HF) with eplerenone that looks promising, as is a meta-analysis in CKD patients - https://t.co/8I0BaN0n9S
Aldosterone antagonists for people with chronic kidney disease requiring dialysis. NNT 14 (death), NNH (Gynecomastia) 38. https://t.co/JFuIAiHvTT
RT @DGBassani: @jbrianbyrd @thebyrdlab Unlikely that in an outcome like mortality there would be much (if any) uncertainty. This Cochrane R…
@jbrianbyrd @thebyrdlab Unlikely that in an outcome like mortality there would be much (if any) uncertainty. This Cochrane Review shows these results are consistent w other trials. https://t.co/A9oOySv8aS
RT @drpatrickholmes: Systematic Review by @cochranecollab Aldosterone antagonists probably ⤵️risk of all‐cause & CV death, PLUS probably…
RT @drpatrickholmes: Systematic Review by @cochranecollab Aldosterone antagonists probably ⤵️risk of all‐cause & CV death, PLUS probably…
RT @drpatrickholmes: Systematic Review by @cochranecollab Aldosterone antagonists probably ⤵️risk of all‐cause & CV death, PLUS probably…
Keenly waiting to see if this will help improve outcomes in survivors of critical illness #PICS #SSCILL @drdhruvparekh @drjminpat
RT @drpatrickholmes: Systematic Review by @cochranecollab Aldosterone antagonists probably ⤵️risk of all‐cause & CV death, PLUS probably…
RT @drpatrickholmes: Systematic Review by @cochranecollab Aldosterone antagonists probably ⤵️risk of all‐cause & CV death, PLUS probably…
RT @drpatrickholmes: Systematic Review by @cochranecollab Aldosterone antagonists probably ⤵️risk of all‐cause & CV death, PLUS probably…
RT @drpatrickholmes: Systematic Review by @cochranecollab Aldosterone antagonists probably ⤵️risk of all‐cause & CV death, PLUS probably…
RT @drpatrickholmes: Systematic Review by @cochranecollab Aldosterone antagonists probably ⤵️risk of all‐cause & CV death, PLUS probably…
RT @drpatrickholmes: Systematic Review by @cochranecollab Aldosterone antagonists probably ⤵️risk of all‐cause & CV death, PLUS probably…
Systematic Review by @cochranecollab Aldosterone antagonists probably ⤵️risk of all‐cause & CV death, PLUS probably reduces morbidity due to CV disease in people with #CKD on #dialysis Interesting with the better tolerated #finerenone on the horizo
Un vieux médicament, qui probablement va devenir un traitement de base en dialyse Aldosterone antagonists for people with chronic kidney disease requiring dialysis - Hasegawa, T - 2021 | Cochrane Library https://t.co/5Qr0mNNsRk
RT @SVNefro: Revisión @CochraneKidney sobre el uso de MRA en #ERC5D, ya no es tiempo de nihilismo terapéutico! RCT 16 💀(mortality)💔 RR 0.3…
RT @SVNefro: Revisión @CochraneKidney sobre el uso de MRA en #ERC5D, ya no es tiempo de nihilismo terapéutico! RCT 16 💀(mortality)💔 RR 0.3…
RT @CochraneKidney: New review: Aldosterone antagonists for people with chronic kidney disease requiring dialysis. Discover the latest at #…
RT @CochraneKidney: New review: Aldosterone antagonists for people with chronic kidney disease requiring dialysis. Discover the latest at #…
RT @SVNefro: Revisión @CochraneKidney sobre el uso de MRA en #ERC5D, ya no es tiempo de nihilismo terapéutico! RCT 16 💀(mortality)💔 RR 0.3…
RT @SVNefro: Revisión @CochraneKidney sobre el uso de MRA en #ERC5D, ya no es tiempo de nihilismo terapéutico! RCT 16 💀(mortality)💔 RR 0.3…
RT @SVNefro: Revisión @CochraneKidney sobre el uso de MRA en #ERC5D, ya no es tiempo de nihilismo terapéutico! RCT 16 💀(mortality)💔 RR 0.3…
RT @SVNefro: Revisión @CochraneKidney sobre el uso de MRA en #ERC5D, ya no es tiempo de nihilismo terapéutico! RCT 16 💀(mortality)💔 RR 0.3…
Revisión @CochraneKidney sobre el uso de MRA en #ERC5D, ya no es tiempo de nihilismo terapéutico! RCT 16 💀(mortality)💔 RR 0.37 (morbidity)💔🧠RR 0.38 NNTB 14 🌐https://t.co/3StQENV1vz @SENefrologia @senjoven @dvdrry @PepaSolerR @SOMANEorg @nefrocat @nefro
RT @CochraneKidney: New review: Aldosterone antagonists for people with chronic kidney disease requiring dialysis. Discover the latest at #…
RT @CochraneKidney: New review: Aldosterone antagonists for people with chronic kidney disease requiring dialysis. Discover the latest at #…
RT @CochraneKidney: New review: Aldosterone antagonists for people with chronic kidney disease requiring dialysis. Discover the latest at #…
RT @CochraneKidney: New review: Aldosterone antagonists for people with chronic kidney disease requiring dialysis. Discover the latest at #…
RT @CochraneKidney: New review: Aldosterone antagonists for people with chronic kidney disease requiring dialysis. Discover the latest at #…
RT @CochraneKidney: New review: Aldosterone antagonists for people with chronic kidney disease requiring dialysis. Discover the latest at #…
RT @CochraneKidney: New review: Aldosterone antagonists for people with chronic kidney disease requiring dialysis. Discover the latest at #…
RT @CochraneKidney: New review: Aldosterone antagonists for people with chronic kidney disease requiring dialysis. Discover the latest at #…
New review: Aldosterone antagonists for people with chronic kidney disease requiring dialysis. Discover the latest at #CochraneEvidence https://t.co/ZTHWRAZaT1 #kidneydisease https://t.co/idcWQ8Vvyv
RT @CochraneJapan: 日本からのコクランレビューが出版されています🇯🇵おめでとうございます🎉🎉 “Aldosterone antagonists for people with chronic kidney disease requiring dialysis…
RT @CochraneJapan: 日本からのコクランレビューが出版されています🇯🇵おめでとうございます🎉🎉 “Aldosterone antagonists for people with chronic kidney disease requiring dialysis…
RT @CochraneJapan: 日本からのコクランレビューが出版されています🇯🇵おめでとうございます🎉🎉 “Aldosterone antagonists for people with chronic kidney disease requiring dialysis…
RT @CochraneJapan: 日本からのコクランレビューが出版されています🇯🇵おめでとうございます🎉🎉 “Aldosterone antagonists for people with chronic kidney disease requiring dialysis…
RT @CochraneJapan: 日本からのコクランレビューが出版されています🇯🇵おめでとうございます🎉🎉 “Aldosterone antagonists for people with chronic kidney disease requiring dialysis…
RT @CochraneJapan: 日本からのコクランレビューが出版されています🇯🇵おめでとうございます🎉🎉 “Aldosterone antagonists for people with chronic kidney disease requiring dialysis…
RT @CochraneJapan: 日本からのコクランレビューが出版されています🇯🇵おめでとうございます🎉🎉 “Aldosterone antagonists for people with chronic kidney disease requiring dialysis…
RT @CochraneJapan: 日本からのコクランレビューが出版されています🇯🇵おめでとうございます🎉🎉 “Aldosterone antagonists for people with chronic kidney disease requiring dialysis…
RT @CochraneJapan: 日本からのコクランレビューが出版されています🇯🇵おめでとうございます🎉🎉 “Aldosterone antagonists for people with chronic kidney disease requiring dialysis…
RT @CochraneJapan: 日本からのコクランレビューが出版されています🇯🇵おめでとうございます🎉🎉 “Aldosterone antagonists for people with chronic kidney disease requiring dialysis…
日本からのコクランレビューが出版されています🇯🇵おめでとうございます🎉🎉 “Aldosterone antagonists for people with chronic kidney disease requiring dialysis” https://t.co/u8m7SgwosE